Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The amino acids in Kabiven are delivered directly into the bloodstream, making them immediately available for protein synthesis, energy production, and metabolic processes. This bypasses the gastrointestinal tract and helps maintain nitrogen balance and tissue repair in patients unable to eat or absorb nutrients.

The dose of Kabiven is individualized by the prescribing clinician based on the patient’s weight, metabolic needs, and clinical condition. Healthcare professionals calculate the appropriate volume and concentration to meet the patient’s protein and caloric requirements.

Safety data for Kabiven in pregnancy and lactation are limited. It should only be used if the potential benefits outweigh any potential risks, and the decision must be made by a qualified healthcare provider after careful assessment.

To order Kabiven, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Kabiven offers a comprehensive blend of essential and non‑essential amino acids in a single intravenous formulation, matching the amino acid profile recommended for adult parenteral nutrition. Compared with products that provide separate amino acid modules, Kabiven simplifies preparation and reduces the risk of dosing errors.

Kabiven must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before use, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration.

Kabiven is administered intravenously, typically through a central venous catheter or a peripheral line using an infusion pump. The infusion rate is set by the clinician according to the prescribed volume and the patient’s tolerance, with regular monitoring of vital signs and laboratory parameters.

Serious risks include anaphylactic reactions, metabolic acidosis, and hyperammonemia, especially in patients with liver dysfunction. Prompt recognition of symptoms such as difficulty breathing, rapid heart rate, or altered mental status is essential, and immediate medical intervention should be initiated.

Kabiven should be avoided in patients with known hypersensitivity to any of its amino acid components, severe renal or hepatic failure where amino acid clearance is compromised, and in those where compatible intravenous solutions cannot be ensured.